Although we did not have survival and follow-up history for the patients used in this study, we did observe that mutations in CASP8 in TCGA HNSCC samples showed a significant decrease in overall survival (Log Rank test P Value of 8.927E-04) (Fig 1C) [17, 18]. This evidence concerns the gene CASP8 and head and neck squamous cell carcinoma.